PCI: Clinical Trials

1 trial for PCI, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 41Recruiting 1

Follow PCI: new trials by email Literature Review of PCI trials Research Report on PCI

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effect of Empagliflozin on Inflammation
Empagliflozin (SGLT2i), Placebo - CAD - Coronary Artery Disease, Inflamation
Phase 4RecruitingHotel Dieu de France Hospital1002025-09-012025-12-18

Narrower conditions

Coronary Artery Disease (1)  ·  Inflammation (1)

Broader conditions

Arterial Occlusive Diseases (1)  ·  Arteriosclerosis (1)  ·  Cardiovascular Diseases (1)  ·  Coronary Disease (1)  ·  Heart Diseases (1)  ·  Myocardial Ischemia (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Vascular Diseases (1)

Interventions

empagliflozin (1)

Sponsors

Hotel Dieu de France Hospital (1)

Countries

Lebanon (1)

Top investigators

Rabih R Azar, MD, MPH (1)